Status: Recruiting
EndoForce Post Approval Study
The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.
Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Phraxis, Inc.Updated: Jan 21, 2026Locations: 2
Eligibility criteria
Patient is ≥18 years of age. [+4]
All contraindications for the EndoForce Connector System according to the IFU. [+2]